Olympia Compounding Pharmacy dba Olympia Pharmacy: Drug Recall
Recall #D-0719-2022 · 03/08/2022
Class II: Risk
Recall Details
- Recall Number
- D-0719-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Olympia Compounding Pharmacy dba Olympia Pharmacy
- Status
- Terminated
- Date Initiated
- 03/08/2022
- Location
- Orlando, FL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2634 vials
Reason for Recall
Product found to be Sub Potent or Exceeded reconstitution time
Product Description
NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00
Distribution Pattern
Nationwide in the USA including Puerto Rico.
Other Recalls by Olympia Compounding Pharmacy dba Olympia Pharmacy
- Class II: Risk 05/09/2022
- Class II: Risk 05/09/2022
- Class II: Risk 05/09/2022
- Class II: Risk 05/09/2022
- Class II: Risk 05/09/2022
View all recalls by Olympia Compounding Pharmacy dba Olympia Pharmacy →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.